Dartmouth researchers conducted the first-ever clinical trial of a generative AI-powered therapy chatbot and found that the software resulted in significant improvements in participants’ symptoms, according to results published March 27 in NEJM AI.People in the study also reported they could trust and communicate with the system, known as Therabot, to a degree that is comparable to working with a mental-health professional.The trial consisted of 106 people from across the United States diagnosed...